Physician profile
William Mcgee
NPI 1023087764
$2,461.37
in general payments reported to CMS, 2019-2025
19 companies · $35.10 in 2025
The $35.10 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $203 · 2021: $796 · 2022: $98.08 · 2024: $87.35 · 2025: $35.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $800.06 | 2019 | |
| Medtronic, INC. | $609.06 | 2021 | |
| Smith+Nephew, INC. | $220.97 | 2019-2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $213.81 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $187.77 | 2019-2021 | |
| Organogenesis INC. | $85.92 | 2022-2025 | Apligraf |
| Kci USA, INC. | $59.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $38.28 | 2019 | |
| Irhythm Technologies, INC. | $35.82 | 2020 | |
| Cardiovascular Systems INC. | $34.25 | 2019 | |
| Abbvie INC. | $33.89 | 2022-2024 | |
| Solventum Corporation | $32.37 | 2024-2025 | 3m Cavilon, Activ.A.C. Ion Progress, V.A.C. Dermatac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.70 | 2019-2021 | |
| Silk Road Medical, INC. | $16.36 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.50 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.16 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.83 | 2019 | |
| Pfizer INC. | $13.07 | 2022 | |
| Kls-Martin L.P. | $6.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.